random sequence generated by a computer program at (AstraZeneca ltd)
90
Structured Review
AstraZeneca ltd
random sequence generated by a computer program at
Random Sequence Generated By A Computer Program At, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-generated+random+number+sequence/random+sequence+generated+by+a+computer+program+at/pmc10879916-946-26-33
Average 90 stars, based on 1 article reviews
Random Sequence Generated By A Computer Program At, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer-generated+random+number+sequence/random+sequence+generated+by+a+computer+program+at/pmc10879916-946-26-33
Average 90 stars, based on 1 article reviews
random sequence generated by a computer program at - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Sequencing:Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis Article Snippet: Random sequence generation (selection bias) , Low risk , Patients were allocated into either group in a proportion of 1:1 by Article Title: Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis Article Snippet: Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were allocated into either group in a proportion of 1:1 by Selection:Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis Article Snippet: Random sequence generation (selection bias) , Low risk , Patients were allocated into either group in a proportion of 1:1 by Article Title: Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis Article Snippet: Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were allocated into either group in a proportion of 1:1 by Blocking Assay:Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis Article Snippet: Random sequence generation (selection bias) , Low risk , Patients were allocated into either group in a proportion of 1:1 by Article Title: Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis Article Snippet: Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were allocated into either group in a proportion of 1:1 by Generated:Article Title: Long‐acting inhaled therapy (beta‐agonists, anticholinergics and steroids) for COPD: a network meta‐analysis Article Snippet: Random sequence generation (selection bias) , Low risk , Patients were allocated into either group in a proportion of 1:1 by Article Title: Long-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysis Article Snippet: Bias Authors’ judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were allocated into either group in a proportion of 1:1 by |